The U.S. Food And Drug Administration is keeping its promise to support competition for generic complex drugs. But for Teva Pharmaceuticals, that push has generated bad news. Last week, the FDA announced that it’s approving Mylan’s generic version of Copaxone — Teva’s best-selling multiple-sclerosis drug. Upon news the Mylan’s generic...
More